Hospital Mater DeiBSP:MATD3 +3.18%83 PB Ratio is 1.08 as of Jun. 25, 2026, which is 31% below its 10-year median of 1.57. GuruFocus rates BSP:MATD3 with a GF Score™ of 83/100 and a GF Value™ of R$5.85 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 611 Healthcare Providers & Services companies, Hospital Mater Dei ranks better than 75.78% on this metric.
The historical rank and industry rank for Hospital Mater Dei's PB Ratio or its related term are showing as below:
BSP:MATD3'
s PB Ratio Range Over the Past 10 Years
Min: 0.83 Med: 1.57 Max: 5.15
Current: 1.08
During the past 9 years, Hospital Mater Dei's highest PB Ratio was 5.15. The lowest was 0.83. And the median was 1.57.
BSP:MATD3's PB Ratio is ranked better than 75.78% of 611
companies
in the Healthcare Providers & Services industry
Industry Median: 1.98
vs BSP:MATD3: 1.08
During the past 12 months, Hospital Mater Dei's average Book Value Per Share Growth Rate was 5.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 1.40% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 29.10% per year.
During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of Hospital Mater Dei was 80.60% per year. The lowest was -26.10% per year. And the median was 11.25% per year.
Back to Basics: PB Ratio
Hospital Mater Dei (BSP:MATD3) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Hospital Mater Dei PB Ratio Related Terms
Hospital Mater Dei PB Ratio Historical Data
* Premium members only.
The historical data trend for Hospital Mater Dei's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Hospital Mater Dei's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hospital Mater Dei PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hospital Mater Dei's PB Ratio distribution charts can be found below:
* The bar in red indicates where Hospital Mater Dei's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Hospital Mater Dei (BSP:MATD3) has a PB Ratio of 1.08 as of Jun. 25, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Hospital Mater Dei and its competitors. This is 31% below median its historical median of 1.57. Over the past decade, Hospital Mater Dei's PB Ratio has ranged from 0.83 to 5.15. According to the industry distribution chart, Hospital Mater Dei ranks #148 out of 611 companies in the Healthcare Providers & Services industry, placing it in the top 24.2%.
Is Hospital Mater Dei's PB Ratio too high?
Hospital Mater Dei's current PB Ratio of 1.08 is 31% below median its 10-year median of 1.57. Over the past 10 years, this metric has ranged from a low of 0.83 to a high of 5.15. The Healthcare Providers & Services industry median PB Ratio is 1.98. Hospital Mater Dei's value of 1.08 is 45.5% below this industry median. Based on the distribution chart, Hospital Mater Dei ranks #148 out of 611 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Hospital Mater Dei has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hospital Mater Dei's PB Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Hospital Mater Dei ranks #148 out of 611 companies for PB Ratio. This places Hospital Mater Dei in the top 24% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.98. Hospital Mater Dei's value of 1.08 is 45.5% below this benchmark. Historically, Hospital Mater Dei's own PB Ratio has ranged from 0.83 to 5.15 over the past decade. While the company's 10-year median is 1.57 vs. the industry median of 1.98, Hospital Mater Dei has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.98, based on 611 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hospital Mater Dei's current PB Ratio of 1.08 is 45.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Hospital Mater Dei and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hospital Mater Dei's current PB Ratio is 1.08, which is 31% below median its own 10-year median of 1.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hospital Mater Dei stock overvalued right now?
Based on GuruFocus' analysis, Hospital Mater Dei (BSP:MATD3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$5.85, compared to a current price of R$4.86 — trading 16.9% below its estimated fair value. The current PB Ratio is 1.08, which is 31% below median its 10-year median of 1.57 and 45.5% below the Healthcare Providers & Services industry median of 1.98. Hospital Mater Dei's overall GF Score™ is 83/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Hospital Mater Dei (BSP:MATD3), the current PB Ratio is 1.08 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hospital Mater Dei (BSP:MATD3) Overvalued in 2026?
Based on GuruFocus' analysis, Hospital Mater Dei stock appears to be undervalued.
The current stock price of R$4.86 is trading 16.9% below its estimated GF Value™ of R$5.85.
GuruFocus considers Hospital Mater Dei to be Modestly Undervalued.
Key valuation signals for BSP:MATD3:
PB Ratio: 1.08 (31% below median its 10-year median of 1.57)
GF Value™: R$5.85 vs. price of R$4.86 (16.9% below fair value)
Industry Position: 45.5% below the Healthcare Providers & Services median (#148 of 611)
No single metric tells the full story. See the BSP:MATD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hospital Mater Dei SA is an integrated healthcare ecosystem that provides hospital and oncological services. The company provides a wide range of healthcare services, including hospitalizations, surgeries, oncology treatments, medical appointments, and diagnostic exams.
83GF Score
Get the complete analysis for BSP:MATD3
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:MATD3 has been successfully added to your 
